WC
QGENF

Whitnell & Co’s QIAGEN NV QGENF Stock Holding History

Whitnell & Co’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-174
Closed -$5K – 414
2016
Q3 		$5K Hold
174
– – ﹤0.01% 312
2016
Q2 		$4K Buy
174
+97
+126% +$2.23K ﹤0.01% 333
2016
Q1 		$2K Hold
77
– – ﹤0.01% 379
2015
Q4 		$2K Hold
77
– – ﹤0.01% 389
2015
Q3 		$2K Buy
+77
New +$2K ﹤0.01% 382

Other funds holding QGENF

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MNA
Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return
HJGA
Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Whitnell & Co's QGENF Position: Q4 2016 in Review

Whitnell & Co sold out of QIAGEN NV (QGENF) in Q4 2016, closing a stake of 174 shares — an estimated $5K sold.

Whitnell & Co first reported a position in QGENF in Q3 2015 and held it in 5 quarters. The position peaked at $5K in Q3 2016. 189 funds tracked by Wall St. Rank hold QGENF as of Q4 2016.

  • Whitnell & Co reported no remaining QIAGEN NV position as of Q4 2016 after selling out during the quarter.
  • Whitnell & Co sold 174 QIAGEN NV shares in Q4 2016, an estimated $5K.
  • Whitnell & Co first reported a position in QIAGEN NV in Q3 2015 and held it in 5 quarters.
  • Whitnell & Co's QIAGEN NV position peaked at $5K in Q3 2016.
  • 189 funds tracked by Wall St. Rank held QIAGEN NV as of Q4 2016.

Based on Whitnell & Co's 13F filing for Q4 2016, filed 2 Feb 2017.